New biologic and targeted therapies are changing the landscape of prurigo nodularis care, offering sustained relief and ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in ...